New clinical trial (not yet open) to watch

Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma See Original Notice Here Identifier: NCT03041701 Sponsor: National Cancer Institute (NCI) Background: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of childhood. Two types are embryonal RMS (ERMS) and alveolar…
Continue Reading »

Focus On Rhabdo Webinar Series – March 5, 2017 – Dr. Zoë Walters

Focus On Rhabdo Webinar Series March 5, 2017 Dr. Zoe Walters - Institute of Cancer Research Epigenetics describes the study and role of specific markers on DNA and associated histone proteins. The work that Zoë has undertaken within Janet’s team at the ICR and during her CWCUK fellowship has focused on the role of proteins…
Continue Reading »

Potential new drug class hits multiple cancer cell targets, boosting efficacy and safety

Potential new drug class hits multiple cancer cell targets, boosting efficacy and safety Date: February 1, 2017 | Source: University of California San Diego Health Sciences | See Original Here Summary: A potential new class of anti-cancer drugs inhibits two or more molecular targets at once, maximizing therapeutic efficiency and safety, report scientists. MYC is…
Continue Reading »

National Cancer Institute and drug companies aim to speed up clinical trials

National Cancer Institute and drug companies aim to speed up clinical trials By Laurie McGinley  | January 11 | Washington Post | See Original Here A squamous cancer cell, in white, is attacked by two T cells, in red, as part of an immune response. (Duncan Comprehensive Cancer Center at Baylor College of Medicine/National Cancer Institute) The…
Continue Reading »

Company Will Raise $1 Billion To Create Blood Test To Detect Cancer

Company Will Raise $1 Billion To Create Blood Test To Detect Cancer Jan 5, 2017 | Matthew Herper, Forbes Staff | See Original Here Jeff Huber Grail, a San Francisco startup that aims to invent a blood test that can detect cancer early, announced this afternoon that it plans to raise $1 billion in venture capital in…
Continue Reading »

Using immune cells to deliver anti-cancer drugs

Using immune cells to deliver anti-cancer drugs Date: January 3, 2017 | Source: Penn State Materials Research Institute | See Original Here Summary: Biomedical engineers have created a smart, targeted drug delivery system using immune cells to attack cancers. Artist's conception of nanoparticle-carrying immune cells that target tumors and release drug-loaded nanoparticles for cancer treatment.…
Continue Reading »

Genetic complexity of cancer cells within the same tumor

Genetic complexity of cancer cells within the same tumor Pioneering research identifies more than 2,000 mutations and illustrates treatment challenges Date: December 28, 2016 | Source: Cedars-Sinai Medical Center | See Original HereSummary: A new study dramatically illustrates the complexity of cancer by identifying more than 2,000 genetic mutations in tissue samples of esophageal tumors. The findings reveal that even…
Continue Reading »

Illuminating cancer: Researchers invent a pH threshold sensor to improve cancer surgery

Illuminating cancer: Researchers invent a pH threshold sensor to improve cancer surgery Date: December 20, 2016 Source: UT Southwestern Medical Center Summary: Researchers have invented a transistor-like threshold sensor that can illuminate cancer tissue, helping surgeons more accurately distinguish cancerous from normal tissue. See Original Here Dr. Darab Syner (left) and Dr. Jinming Gao (right)…
Continue Reading »

One Obstacle to Curing Cancer: Patient Data Isn’t Shared

One Obstacle to Curing Cancer: Patient Data Isn’t Shared By Richard G. Haermesh and Kathy Giusti | Harvard Business Review | Noember 28, 2016 | See Original Here Scientific efforts to find cures for cancer will be severely hampered if the scientific community does not change the ways in which patient data is collected, shared,…
Continue Reading »

Giving Tuesday – Children’s Cancer Therapy Development Institute

Giving Tuesday Heavy on our hearts this week as we gather with friends and family for Thanksgiving are the families we work so closely with who are impacted by childhood cancer. We are honored to be your partners in hope. There is more going on at the lab than we can convey in a short…
Continue Reading »
Skip to toolbar